[
1. Michael MB, Erika OW, Robert JG. Diagnosis and Management of Endometrial Cancer. Fam Physician. 2016 Mar 15;93(6):468-74.
]Search in Google Scholar
[
2. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer Incidence and Mortality Worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2015 Mar 1;136(5 ): E359-86. https://doi:10.100injc.2921010.1002/ijc.2921025220842
]Search in Google Scholar
[
3. Andrew MG, James A.L.B, Michael JK. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring. Cancer Metastatic Rev. 2015; 34(1): 145155.- Published online 2015 Feb 27. https://doi:10.1007/s10555-015-9551-7
]Search in Google Scholar
[
4. Romaszko-Wojtowicz A, Buciñski A, Doboszyñska A. Impact of smoking on multiple primary cancers survival: a retrospective analysis. Clinical and Experimental Medicine. 2018 Aug;18(3):391-397. https://doi:10.1007/s10238-018-0498-1.10.1007/s10238-018-0498-129550986
]Search in Google Scholar
[
5. Jenny N, Toshima ZP, Khalil H, Elisabeth KS, Zakaria E, Per K, Salmir N, and Aniko K. Previously diagnosed multiple primary malignancies in patients with breast carcinoma in Western Sweden between 2007 and 2018. Breast Cancer Res Treat. 2020 Nov.; 184(1): 221228. https://doi:10.1007/s10549-020-05822-z10.1007/s10549-020-05822-z756870932740808
]Search in Google Scholar
[
6. Mehmet SC, Suresh M. Multiple Primary Tumors over a lifetime. Oncology (Williston Park). 2019 Jul 16;33(7): 629384
]Search in Google Scholar
[
7. Pariyada T, Bhoom S, Nurchavadee V, Panudeth J, Benjarat T, Cholticha V, Suwanit T, Somsri L, and Vitton C. Risks and cancer associations of metachronous and synchronous multiple primary cancers. BMC Cancer. 2021 Sep 23; 21(1): 1045. https://doi:10.1186/s12885-021-08766-910.1186/s12885-021-08766-9846196934556087
]Search in Google Scholar
[
8. Chang-Ching Y, Peng-Hui W, Chiung-Ru L, Min-Shyen Y, Kuan-Cjong CF. Synchronous breast invasive ductal carcinoma and endometrial endometrioid adenocarcinoma: A case report. J Obstet Gynaecol Res. 2011 Sep; 37(9):1246-9. https://doi.org/10.1111/j.1447-0756.2010.01502.x10.1111/j.1447-0756.2010.01502.x21518130
]Search in Google Scholar
[
9. Lv M, Zhang X, Shen Y, Wang F, Yang J, Chen Z, Li P, Zhang X, Li S, Yang J. Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors. Medicine (Baltimore). 2017 Apr;96 (17):e6799. https://doi:10.1097/MD.000000000000679910.1097/MD.0000000000006799541328628445321
]Search in Google Scholar
[
10. Ali AT. Risk factors for endometrial cancer. Ceska Gynekologie. 2013 nov; 78(5):448-459
]Search in Google Scholar
[
11. Sun YS, Zhao Z, Yang ZN, Xu F, Lu HJ, Zhu ZY, Shi W, Jiang J, Yao PP, Zhu HP. Risk Factors and Prevention of Breast Cancer. International Journal of Biological Sciences. 2017; 13(11): 13871397. https://doi:10.7150/ijbs.2163510.7150/ijbs.21635571552229209143
]Search in Google Scholar
[
12. Adel E.B. MDCT evaluation of synchronous breast carcinoma and other solid malignancies. Breast Disease. 2021;40(4):275-281. https://doi:10.3233/BD-20106510.3233/BD-20106534120894
]Search in Google Scholar
[
13. Matthias M and Rosemarie F. MRI of endometrium cancer how we do it. Cancer Imaging. 2016 May 9;16:11. https://doi:10.1186/s40644-016-0069-110.1186/s40644-016-0069-1486077127157039
]Search in Google Scholar
[
14. Gee MS, Atri M, Bandos AI, Mannel RS, Gold MA, Lee Si. Identification of Distant Metastatic Disease in Uterine Cervical and Endometrial Cancers with FDG PET/CT: Analysis from the ACRIN 6671/GOG 0233 Multicenter Trial. Radiology. 2018 Apr; 287(1): 176184. https://doi:10.1148/radiol.201717096310.1148/radiol.2017170963588163929185901
]Search in Google Scholar
[
15. Bruzonne M, Miglietta L, Franzone P, Gadducci A, Boccardo F. Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients-Author links open overlay panel. Gynecologic Oncology. 2004 May; 93(2):345-52. https://doi.org/10.1016/j.ygyno.2004.02.00810.1016/j.ygyno.2004.02.00815099944
]Search in Google Scholar
[
16. Greven KM, Lanciano RM, Corn B, Case D, Randall ME. Pathologic stage III endometrial carcinoma. Prognostic factor and patterns of recurrence. Cancer. 1993 June 1;71(11):3697-702. https://doi:10.1002/1097-0142(19930601)71:11---lt---3697::aid-cncr2820711137---gt---3.0.co;2-u.10.1002/1097-0142(19930601)71:11<3697::AID-CNCR2820711137>3.0.CO;2-U
]Search in Google Scholar
[
17. Georgescu MT, Georgescu DE, Georgescu TF, Serbanescu GL. Changing the prognosis of metastatic cervix uteri adenosquamous carcinoma through multimodal approach: a case report. Case reports in Oncology. 2020 Sep-Dec; 13(3): 1545-1551. https://doi:10.1159/00051156410.1159/000511564784173733564296
]Search in Google Scholar
[
18. Georgescu MT, Moldoveanu VG, Ileanu BV, Anghel R. Dosimetric influence of uterus position in cervix cancer high-dose-rate brachytherapy. Romanian Journal in Physics. 2016 Vol. 61, Nos. 910, P. 15571566.
]Search in Google Scholar
[
19. Georgescu MT, Anghel R. Variation in uterus position prior to brachytherapy of cervix: A case report. Journal of Medicine and Life. 2017 Jan-Mar; 10(1): 9093.
]Search in Google Scholar
[
20. Shu-Lian W, Hui F, Yong-Wen S, Wei-Hu W, Chen H, Yue- Ping L, Jing J, Xin-Fan L, Zi-hao Y, Hua R, Ning L, Ning-Ning L, Yu T, Yuan Y, Shu-Nan Q, Guang-yi S, Ran P, Shuai L, Bo C, Yong Y, Ye-Xiong L. Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomized, non-inferiority, open-label. The Lancet Oncology. 2019 Mar;20(3):352-360. https://doi:10.1016/S1470-2045(18)30813-110.1016/S1470-2045(18)30813-130711522
]Search in Google Scholar
[
21. Schwartz GF, Cantor RI, Biermann WA. Neoadjuvant Chemotherapy Before Definitive Treatment for Stage III Carcinoma of the Breast. Archives of Surgery(Chicago, III:1960). 1987 Dec; 122(12):1430-1434. https://doi:10.1001/archsurg.1987.0140024007801410.1001/archsurg.1987.014002400780143689121
]Search in Google Scholar
